We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Neurimmune has entered into a collaboration with Ono Pharmaceutical focused on the development of human antibodies against a novel therapeutic target for neurodegenerative diseases.